Found 317 matching trials
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive PHASE1 Background:
The National Cancer Institute (NCI) Surgery Branch has develop...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer PHASE1 This phase I clinical trial evaluates the safety and feasibility of adminis...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Allo HSCT Using RIC for Hematological Diseases PHASE2 This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma PHASE1 This phase I trial studies the side effects and best dose of genetically mo...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor PHASE2 This is a Phase II, open-label, two strata, multicenter, prospective study ...
Show More Location
H. Lee Moffitt Cancer Center
Learn More & Join Trial
Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma PHASE1 Neuroblastoma is a malignant tumor of the sympathetic nervous system. It is...
Show More Location
Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian
Learn More & Join Trial
Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy PHASE2 Chronic inflammatory demyelinating polyneuropathy is disease believed to be...
Show More Location
Northwestern University, Feinberg School of Medicine
Learn More & Join Trial
Preservation of Ovarian Function After Hematopoietic Cell Transplant PHASE2 Women undergoing myeloablative allogeneic hematopoietic cell transplant (MA...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT PHASE2 To evaluate if hyper-fractionated TBI or TMLI followed by Treg/Tcon adoptiv...
Show More Location
University of Perugia
Learn More & Join Trial
Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma PHASE2 This experiment will test the safety and effectiveness of a treatment for m...
Show More Location
National Cancer Institute (NCI)
Learn More & Join Trial